Pharmaceutical safety in Uzbekistan: Analysis of the current state of pharmacovigilance

Yoqubova, Umidahon, Ёкубова, Умидахон, Yoqubova, Umidaxon

Жамият ва инновациялар / Общество и инновации / Society and innovations · 2024-yil

Annotatsiya

Pharmacontrol is a key system that ensures control over the safety of medicines and the protection of the health of the population. Its development is linked to historical events, such as the thalidomide disaster, which stimulated the creation of international monitoring systems. In Uzbekistan, the national pharmaceutical control system has been actively developing since 1998. The Health Ministry, the Pharmaceutical Industry Development Agency and the Pharmaceutical Product Safety Center play a leading role in this process. These structures are involved in collecting data on side effects, risk management, informing the population, and developing international cooperation. Effective coordination between these bodies contributes to the implementation of advanced standards, improvement of the regulatory framework and increasing the level of citizens' trust in the healthcare system. The purpose of this study is to analyze the pharmacontrol system in Uzbekistan, its role and effectiveness in ensuring the safety of medicinal products. The research aims to study the current state of the national system, identify its problematic aspects, and develop recommendations for its further improvement. The relevance of the topic is determined by the global increase in the use of pharmaceutical products and the need to minimize the risks associated with side effects and adverse reactions to medications. The research methodology includes an analysis of the regulatory framework, statistical data, as well as a comparative analysis of international pharmaceutical control standards and the practice of their implementation in countries with a developed monitoring system. The research findings demonstrate significant achievements in Uzbekistan in establishing a pharmacovigilance system. Improvements have been achieved in the regulatory framework, risk management, and international cooperation. However, challenges remain related to integrating international standards and improving the quality of data collection.

Maqola ma’lumotlari
MualliflarYoqubova, Umidahon, Ёкубова, Умидахон, Yoqubova, Umidaxon
JurnalЖамият ва инновациялар / Общество и инновации / Society and innovations
Nashr sanasi2024-11-25
Jild5
Son11/S
Betlar208-217
TilRus
DOI10.47689/2181-1415-vol5-iss11/s-pp208-217

Kalit so‘zlar

Фармаконадзор, побочные реакции, безопасность лекарств, международные стандарты, постмаркетинговый надзор, фармацевтические компании, Всемирная организация здравоохранения (ВОЗ), Pharmacontrol, side effects, drug safety, international standards, post-marketing control, pharmaceutical companies, World Health Organization (WHO), Farmakonazorat, nojo‘ya reaksiyalar, dori xavfsizligi, xalqaro standartlar, marketingdan keyingi kuzatuv, farmatsevtika kompaniyalari, Jahon sog‘liqni saqlash tashkiloti (JSST)

Ilmiy soha

Жамият ва инновациялар / Общество и инновации / Society and innovations jurnalidan boshqa maqolalar

Жамият ва инновациялар / Общество и инновации / Society and innovations — barcha maqolalar